Medicortex Finland Oy

Medicortex Finland is focused on developing a diagnostic kit for traumatic brain injury based on a new biomarker.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Turku, Finland
  • Currency EUR
  • Founded June 2014
  • Employees 6
  • Incorporation Type LLC
  • Website medicortex.fi

Company Summary

Medicortex has identified novel biomarkers for rapid detection of traumatic brain injury (TBI). Medicortex is located in Turku, Finland, where the business environment in medical diagnostics is active. Medicortex has clinical proof-of-concept for the biomarker, and seeks funding for prototype development and pediatric clinical trial. Our team is international, educated and experienced, having diverse background in business, medicine and science.

Team

  • Adrian Harel
    CEO

    Adrian Harel has a PhD in neurobiology from the world-renowned Weizmann Institute of Science in Israel, and an MBA from the University of Haifa. Dr. Harel combines a broad scientific education with extensive regulatory, clinical, and managerial experience. Prior to founding Medicortex in 2014, he served as CEO of several companies that specialize in early-stage drug discovery and development.

  • Medical Director

    Dr. Mårten Kvist has more than 30 years of experience in research, medical education, general practice, health care administration and international collaboration. Appointed as Associate Professor at University of Turku and University of Lapland.

  • Head of R&D

    Dr. Välimaa has biotechnology PhD from University of Turku. He has years of experience in the research and development of techniques and methods for medical diagnostics and bioanalytics.

  • Clinical Research Coordinator

    Three years of experience in the area.
    Bachelor degree in Biotechnology and Diagnostics.
    GCP-training completed.

  • Product Manager

    PhD, Biological Sciences. Skills in research and clinical data analysis. Experience in conducting and leading research projects. Designed and executed biological experiments in cancer biology, coordinating a team of clinicians, scientists and students, and published results in high-impact scientific journals. Also has experience in preparing funding applications.

  • Tomas Ward
    International Business Development

    Mr. Ward has experience in managerial positions of private and public medical companies. Experience in successful market launch and IPO in the past. Has successfully transformed a company from a technology driven company to a market driven company achieving a forerunner position internationally, starting from a position with three employees, technology not ready developed and no visibility in the market.

  • Maria Grönman
    Project Manager

    Dr. Grönman has made her PhD thesis on PET-imaging and she has experience in neuroscience and neuroimaging techniques.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free